Adcock Ingram Holdings Ltd (AIP):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Adcock Ingram Holdings Ltd (AIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C11534)・商品コード:DATA904C11534
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:37
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Midrand, South Africa.

Adcock Ingram Holdings Ltd (AIP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 12
Private Equity 13
Actis Rumored To Acquire Adcock Ingram For US$1.25 Billion 13
Partnerships 14
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15
Asset Transactions 16
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 16
Acquisition 17
Adcock Ingram to Acquire Genop 17
Adcock Ingram Acquires Virtual Logistics 18
Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19
Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20
Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21
BB Investment Acquires 32.03% Stake In Adcock Ingram 22
Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For US$393 Million 23
Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25
Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26
Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27
Adcock Ingram Holdings Ltd – Key Competitors 28
Adcock Ingram Holdings Ltd – Key Employees 29
Adcock Ingram Holdings Ltd – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 31
Recent Developments 32
Financial Announcements 32
Aug 29, 2018: The Adcock Ingram reports a positive trading performance 32
Corporate Communications 34
Jan 29, 2018: Adcock Ingram Holdings: Change to the Board of Directors 34
Other Significant Developments 35
Aug 29, 2018: Adcock Ingram Holdings – Group annual results and cash dividend declaration 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 12
Actis Rumored To Acquire Adcock Ingram For US$1.25 Billion 13
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 16
Adcock Ingram to Acquire Genop 17
Adcock Ingram Acquires Virtual Logistics 18
Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19
Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20
Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21
BB Investment Acquires 32.03% Stake In Adcock Ingram 22
Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For US$393 Million 23
Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25
Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26
Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27
Adcock Ingram Holdings Ltd, Key Competitors 28
Adcock Ingram Holdings Ltd, Key Employees 29
Adcock Ingram Holdings Ltd, Subsidiaries 30
Adcock Ingram Holdings Ltd, Joint Venture 31

List of Figures
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★調査レポート[Adcock Ingram Holdings Ltd (AIP):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C11534)販売に関する免責事項を必ずご確認ください。
★調査レポート[Adcock Ingram Holdings Ltd (AIP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆